LLY
Ticker
Eli Lilly
Company
Biopharma
Industry
Healthcare
Sector
+
2009
+
2010
+
2011
+
2012
+
2013
+
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
5.7%5.2%-6.9%2.3%-15.1%1.7%6.3%7.8%7.4%-9.1%9.9%15.4%0.8%19.6%32.0% 36.8%
Revenue Growth QoQ
Gross Margin
80.6%81.1%79.1%78.8%78.8%74.9%74.8%73.4%73.5%73.8%78.8%77.7%74.2%76.8%79.2%81.3% 82.6%
EBITDA Margin
31.5%34.1%28.4%27.4%29.5%20.6%20.6%23.4%16.2%21.7%27.8%30.1%27.9%30.3%23.4%32.6% 35.9%
Operating Margin
25.6%28.3%22.8%20.9%23.2%13.6%13.5%16.3%9.4%15.2%22.3%24.7%22.4%25.0%18.9%28.6% 32.4%
Profit Margin
19.8%22.0%17.9%18.1%20.3%12.2%12.1%12.9%-0.9%13.2%37.3%25.2%19.7%21.9%15.4%23.5% 25.9%
FCF / EBITDA
51.9%72.8%85.9%68.8%68.9%71.7%41.5%77.0%122.3%80.9%61.3%69.2%75.3%60.5%9.9%25.6% 25.5%